Raffles Medical Group Ltd
SGX:BSL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Raffles Medical Group Ltd
SGX:BSL
|
SG |
|
Pendragon PLC
LSE:PDG
|
UK |
|
Towa Pharmaceutical Co Ltd
TSE:4553
|
JP |
|
Landstar System Inc
NASDAQ:LSTR
|
US |
|
Passage Bio Inc
NASDAQ:PASG
|
US |
|
KP Tissue Inc
TSX:KPT
|
CA |
|
Manila Water Company Inc
OTC:MWTCF
|
PH |
|
IFS Capital Ltd
SGX:I49
|
SG |
|
Cintas Corp
NASDAQ:CTAS
|
US |
Wall Street
Price Targets
BSL Price Targets Summary
Raffles Medical Group Ltd
According to Wall Street analysts, the average 1-year price target for
BSL
is 1.28 SGD
with a low forecast of 1.21 SGD and a high forecast of 1.37 SGD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is BSL's stock price target?
Price Target
1.28
SGD
According to Wall Street analysts, the average 1-year price target for
BSL
is 1.28 SGD
with a low forecast of 1.21 SGD and a high forecast of 1.37 SGD.
What is Raffles Medical Group Ltd's Revenue forecast?
Projected CAGR
5%
For the last 14 years the
compound annual growth rate for
Raffles Medical Group Ltd's revenue is
8%.
The projected
CAGR
for the next 3 years is
5%.
What is Raffles Medical Group Ltd's Operating Income forecast?
Projected CAGR
7%
For the last 14 years the
compound annual growth rate for
Raffles Medical Group Ltd's operating income is
3%.
The projected
CAGR
for the next 3 years is
7%.
What is Raffles Medical Group Ltd's Net Income forecast?
Projected CAGR
9%
For the last 14 years the
compound annual growth rate for
Raffles Medical Group Ltd's net income is
2%.
The projected
CAGR
for the next 3 years is
9%.
